Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF – Get Free Report) was the target of a significant growth in short interest in the month of October. As of October 15th, there was short interest totaling 120 shares. Based on an average daily volume of 2,132 shares, the days-to-cover ratio is presently 0.1 days.
Algernon Pharmaceuticals Stock Down 9.6%
AGNPF opened at $0.24 on Friday. The company has a fifty day simple moving average of $0.31 and a 200 day simple moving average of $0.22. Algernon Pharmaceuticals has a twelve month low of $0.22 and a twelve month high of $0.64.
Algernon Pharmaceuticals Company Profile
Algernon Pharmaceuticals is a Canadian clinical-stage pharmaceutical development company focused on researching and developing therapies for unmet medical needs. The company’s strategy has centered on drug repurposing, which involves evaluating previously studied compounds for potential use in new disease indications.
Its research programs have included NP-120, an ifenprodil-based therapy investigated for conditions such as idiopathic pulmonary fibrosis and other serious respiratory diseases.
Featured Articles
- Five stocks we like better than Algernon Pharmaceuticals
- Starbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
Receive News & Ratings for Algernon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Algernon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
